| |
Chemotherapy group
|
Chemoradiotherapy group
| |
|---|
|
(n = 489)
|
(n = 75)
|
P
|
|---|
|
Cancer staging
|
|
N factor
| | | | |
0.12
|
|
N1
|
243
|
(49.7)
|
30
|
(40.0)
| |
|
N2
|
246
|
(50.3)
|
45
|
(60.0)
| |
|
T factor
| | | | |
0.31
|
|
T0–1
|
203
|
(41.5)
|
37
|
(49.3)
| |
|
T2
|
192
|
(39.3)
|
21
|
(28.0)
| |
|
T3–4
|
90
|
(18.4)
|
16
|
(21.3)
| |
|
Tx
|
4
|
(0.8)
|
1
|
(1.3)
| |
|
Age (years)
| | | | |
0.97
|
|
18–49
|
24
|
(4.9)
|
3
|
(4.0)
| |
|
50–64
|
149
|
(30.5)
|
22
|
(29.3)
| |
|
65–74
|
242
|
(49.5)
|
39
|
(52.0)
| |
|
≥ 75
|
74
|
(15.1)
|
11
|
(14.7)
| |
|
Sex
| | | | |
0.038
|
|
Male
|
379
|
(77.5)
|
66
|
(88.0)
| |
|
Female
|
110
|
(22.5)
|
9
|
(12.0)
| |
|
Body mass index (kg/m2)
| | | | |
0.83
|
|
< 18.5
|
33
|
(6.8)
|
7
|
(9.3)
| |
|
18.5–24.9
|
325
|
(66.5)
|
48
|
(64.0)
| |
|
≥ 25
|
127
|
(26.0)
|
19
|
(25.3)
| |
|
Missing
|
4
|
(0.8)
|
1
|
(1.3)
| |
|
Charlson comorbidity index
| | | | |
0.32
|
|
0–2
|
316
|
(64.6)
|
44
|
(58.7)
| |
|
≥ 3
|
173
|
(35.4)
|
31
|
(41.3)
| |
|
Activity of daily life (Barthel index)
| | | | |
0.99
|
|
Independent (100–95)
|
465
|
(95.1)
|
71
|
(94.5)
| |
|
Dependent (≤90)
|
12
|
(2.5)
|
2
|
(2.7)
| |
|
Missing
|
12
|
(2.5)
|
2
|
(2.7)
| |
- Data expressed as number (%) in each group
